Discontinued — last reported Q4 '25

Other

Proceeds From Issuance Of Secured Debt

Year-over-year, this metric declined by 100.0%, from $37.50M to $0.00.

Analysis

StatementIncome Statement
SectionOther
CategoryLeverage
SignalContext dependent
VolatilityModerate
First reportedQ1 2015
Last reportedQ4 2025

How to read this metric

An increase indicates active use of asset-backed financing to fund operations or growth, while a decrease may suggest a shift toward unsecured debt or reduced borrowing needs.

Detailed definition

This metric represents the total cash inflows generated from the issuance of debt instruments that are collateralized by...

Peer comparison

Common in REITs and capital-intensive industries where asset-backed lending is a standard financing tool.

Metric ID: other_proceeds_from_issuance_of_secured_debt

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$0.00$350.00M$0.00$150.00M$0.00
YoY Change-100.0%-100.0%
Range$0.00$350.00M
Avg YoY Growth-100.0%
Median YoY Growth-100.0%

Frequently Asked Questions

What is Insmed's proceeds from issuance of secured debt?
Insmed (INSM) reported proceeds from issuance of secured debt of $0.00 in Q4 2025.
How has Insmed's proceeds from issuance of secured debt changed year-over-year?
Insmed's proceeds from issuance of secured debt decreased by 100.0% year-over-year, from $37.50M to $0.00.
What does proceeds from issuance of secured debt mean?
Cash received from borrowing money that is backed by specific company assets.